Xusto Fernandez

A Coruna, GA 15006, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants.

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants.

Journal: Circulation

Published: August 29, 2025

Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy.

Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy.

Journal: Journal of clinical medicine

Published: February 23, 2021

Value of a comprehensive exercise echocardiography assessment for patients with hypertrophic cardiomyopathy.

Value of a comprehensive exercise echocardiography assessment for patients with hypertrophic cardiomyopathy.

Journal: Journal of cardiology

Published: September 07, 2020

Genotype-phenotype correlations in hypertrophic cardiomyopathy: a multicenter study in Portugal and Spain of the TPM1 p.Arg21Leu variant.

Genotype-phenotype correlations in hypertrophic cardiomyopathy: a multicenter study in Portugal and Spain of the TPM1 p.Arg21Leu variant.

Journal: Revista espanola de cardiologia (English ed.)

Published: May 07, 2020

Prognostic implications of pathogenic truncating variants in the TTN gene.

Prognostic implications of pathogenic truncating variants in the TTN gene.

Journal: International journal of cardiology

Published: April 08, 2020

Clinical utility of genetic testing in patients with dilated cardiomyopathy.

Clinical utility of genetic testing in patients with dilated cardiomyopathy.

Journal: Medicina clinica

Published: February 10, 2020

The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy.

The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy.

Journal: European heart journal

Published: April 14, 2018

Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy.

Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy.

Journal: Journal of the American College of Cardiology

Published: February 25, 2018

Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Journal: International journal of cardiology

Published: May 29, 2017

Large Family With Marfan Syndrome Demonstrating the Pathogenicity of a "Synonymous" Variant (p.Ile2118=) in the Fibrillin-1 Gene.

Large Family With Marfan Syndrome Demonstrating the Pathogenicity of a "Synonymous" Variant (p.Ile2118=) in the Fibrillin-1 Gene.

Journal: Revista espanola de cardiologia (English ed.)

Published: August 08, 2016

Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: The International Stress Echo Registry.

Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: The International Stress Echo Registry.

Journal: International journal of cardiology

Published: February 28, 2016

Exercise echocardiography and cardiac magnetic resonance imaging to predict outcome in patients with hypertrophic cardiomyopathy.

Exercise echocardiography and cardiac magnetic resonance imaging to predict outcome in patients with hypertrophic cardiomyopathy.

Journal: European heart journal. Cardiovascular Imaging

Published: November 28, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026